Dual pathology, amplified risk? Understanding outcomes in TLS with concurrent heart failure

Authors

• Jawad Ahmed
• Farheen Malik
• Osama Mohiuddin
• Dua Azim, Rochester Regional HealthFollow
• Fnu Bhuvan
• Eliza Aisha
• Hanzala Jehangir
• Aaysha Kapila
• Tareq Braik

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Journal of Clinical Oncology

Conference Name

American Society of Clinical Oncology (ASCO) Annual Meeting

Conference Date

2026-05-29 - 2026-06-02

First Page

e18618

DOI

10.1200/JCO.2026.44.16_suppl.e18618

Volume

44

Issue

16_suppl

Publication Date

6-1-2026

Recommended Citation

Ahmed, J., Malik, F., Mohiuddin, O., Azim, D., Bhuvan, F., Aisha, E., Jehangir, H., Kapila, A., & Braik, T. (2026). Dual pathology, amplified risk? Understanding outcomes in TLS with concurrent heart failure. Journal of Clinical Oncology, 44 (16_suppl), e18618. https://doi.org/10.1200/JCO.2026.44.16_suppl.e18618